Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log
![]() | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
August 25, 2024
editRenamed
edit- Draft:List of investigational social anxiety disorder drugs renamed to List of investigational social anxiety disorder drugs.
Assessed
editAugust 24, 2024
editRenamed
edit- Antihypertensive drug renamed to Antihypertensive.
- JJC8-088 renamed to JJC8-088.
- Draft:Modafiendz renamed to Modafiendz.
- RDS03-94 renamed to RDS03-94.
Reassessed
edit- Lobeline (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
Assessed
edit- AZD2327 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Antihypertensive (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Top-Class. (rev · t)
- List of Lambda Kappa Sigma chapters (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Draft:Pranas Šimanauskas (talk) assessed. Importance assessed as NA-Class. (rev · t)
August 23, 2024
editRenamed
edit- Draft:LSN2463359 renamed to LSN2463359.
- SR-95103 renamed to Famiraprinium.
Assessed
edit- Famiraprinium (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- L-701324 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Ondelopran (talk) assessed. Quality assessed as NA-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
August 22, 2024
editRenamed
edit- CRL-40,940 renamed to Flmodafinil.
- CRL-40,941 renamed to Fladrafinil.
Assessed
edit- Fladrafinil (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Flmodafinil (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Lazertinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
August 20, 2024
editReassessed
edit- 3-Hydroxyaspartic acid (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Gamma-Hydroxybutyraldehyde (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
- Inosine pranobex (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
- PDE4 inhibitor (talk) reassessed. Quality rating changed from Redirect-Class to Start-Class. (rev · t) Importance rating changed from NA-Class to Unknown-Class. (rev · t)